Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The challenge of approving add-on therapies for patients with metastatic cancer

Dr David Montgomery, Alexander Smith
The challenge of approving add-on therapies for patients with metastatic cancer ( Dr David Montgomery, Alexander Smith )
5 Jul 2017

Molecular medicine in lung cancer

Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany
Molecular medicine in lung cancer ( Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany )
4 Jul 2017

Biomarker research in breast cancer

Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Biomarker research in breast cancer ( Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium )
4 Jul 2017

New biomarkers for response to immunotherapy

Prof Antoni Ribas - University of California, Los Angeles, USA
New biomarkers for response to immunotherapy ( Prof Antoni Ribas - University of California, Los Angeles, USA )
4 Jul 2017

Current and future immune approaches in precision medicine

Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France
Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )
4 Jul 2017

Precision medicine enabled histology agnostic development of immunotherapeutics

Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017

Incorporating liquid biopsies into clinical trials

Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
Incorporating liquid biopsies into clinical trials ( Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor,  USA )
4 Jul 2017

Big data, scientific wellness and transforming healthcare

Prof Leroy Hood - Systems Biology, Seattle, USA
Big data, scientific wellness and transforming healthcare ( Prof Leroy Hood - Systems Biology, Seattle, USA )
4 Jul 2017

Redesigning clinical trials in the era of precision medicine

Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA
Redesigning clinical trials in the era of precision medicine ( Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA )
4 Jul 2017

Genomic-driven clinical studies in breast cancer

Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic-driven clinical studies in breast cancer ( Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jul 2017

Genomic predictors of treatment response in prostate cancer

Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017

Synthetic lethality as a basis to select drug combinations

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland
Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )
4 Jul 2017